---
title: "PRECISE: SG100K Driver Projects"
permalink: /precise-sg100k-driver-projects/
variant: tiptap
description: ""
third_nav_title: Our Data Users
---
<h4><strong>Computation of genome - wide LD scores and matrices from the SG100K resource</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Li Jingmei</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Rajkumar s/o Dorajoo</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Khor Chiea Chuen </strong>A*STAR Genome Institute
of Singapore</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<p>Taking reference from similar work performed by the Pan-UK Biobank, the
team will compute in-sample dosage-based LD matrices and scores for each
of the three major ancestry groups in SG100K:</p>
<ol data-tight="true" class="tight">
<li>
<p>LD score regression analysis to estimate heritabilities</p>
</li>
<li>
<p>Fine-mapping analysis to identify causal variants of well-powered complex
traits</p>
</li>
</ol>
<p>The plan is to make the LD matrices available in Hail's BlockMatrix format
or similar. LD scores are also made available in LDSC-compatible flat files
(.l2.ldscore.gz and .M_5_50).</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> A*STAR Genome Institute of Singapore</p>
<hr>
<h4><strong>Chronic liver disease is a significant risk factor for adverse cardiometabolic outcomes</strong></h4>
<blockquote>
<p><strong>Topic: Tandem Repeats</strong>
</p>
</blockquote>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Mark Chan</strong>
</p>
<p>National University Hospital
<br>Cardiology</p>
</li>
<li>
<p><strong>Co-Lead PI: Dr Nicholas Chew</strong>
<br>National University Hospital
<br>Cardiology</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Investigate associations between established non-invasive Chronic Liver
Disease (CLD) biomarkers and cardiometabolic outcomes</p>
</li>
<li>
<p>Evaluate how these associations relate to major adverse cardiac events.</p>
</li>
<li>
<p>Examine whether these associations with CLD are independent from associated
metabolic disease.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> A*STAR Genome Institute of Singapore,
Duke-NUS Medical School, National Neuroscience Institute</p>
<hr>
<h4><strong>An integrated pharmacoeconomic- pharmacokinetic framework for prioritising and testing clinically important drug-gene interactions</strong></h4>
<blockquote>
<p><strong>Topic: Pharmacogenomics</strong>
</p>
</blockquote>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Dr Janice Goh</strong>
<br>A*STAR Bioinformatics Institute</p>
</li>
<li>
<p><strong>Co-Lead PI: A/P Wee Hwee</strong>
</p>
<p><strong>Lin</strong>
<br>National University of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Dr Nicolas</strong>
</p>
<p><strong>Bertin</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Evaluate the occurrence of known drug- gene interactions based on EHR
data and its impact on efficacy and toxicity.</p>
</li>
<li>
<p>Explore genotype-drug response associations using SG100K and linked EHR
datasets augmented by a dedicated pipeline for haplotyping highly polymorphic
drug metabolising enzyme CYP2D6.</p>
</li>
<li>
<p>Develop a pharmacokinetics-informed framework for evaluating and ranking
both known and novel drug-gene = sets for clinical action to make dose
recommendations.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> A*STAR Bioinformatics Institute,
National University of Singapore, A*STAR Genome Institute of Singapore</p>
<hr>
<h4><strong>Genetic variants contributing to clonal haematopoiesis across diverse Asian genomes</strong></h4>
<blockquote>
<p><strong>Topic: Clonal Haematopoiesis</strong>
</p>
</blockquote>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Prof Ong Sin</strong>
</p>
<p><strong>Tiong</strong>
<br>Duke-NUS Medical School</p>
</li>
<li>
<p><strong>Co-Lead PI: Prof Ashok</strong>
</p>
<p><strong>Venkitaraman</strong>
<br>National University of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Prof Chng Wee</strong>
</p>
<p><strong>Joo</strong>
<br>National University of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Prof John Chambers</strong>
<br>Lee Kong Chian School of Medicine</p>
</li>
<li>
<p><strong>Co-Lead PI: Prof Nicolas Bertin</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Determine age-related incidence of clonal haematopoiesis (CH) among our
three major ancestry groups.</p>
</li>
<li>
<p>Correlate CH status with clinical metadata, measures of ageing and disease
incidence, and disease-related</p>
<p>variables including biomarkers.</p>
</li>
<li>
<p>Discover novel genetic associations with CH.</p>
</li>
<li>
<p>Integrate functional genomics for novel Asian CH driver mutation discovery
and validation.</p>
</li>
<li>
<p>Correlate CH status with cell clusters and gene expression signatures
in the AIDA scRNA-seq dataset.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> Duke-NUS Medical School, National
University of Singapore, Lee Kong Chian School of Medicine, A*STAR Genome
Institute of Singapore, National University Hospital, Singapore General
Hospital</p>
<p></p>